Price
Financials
Consolidated, Rs crore| Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.98 | 13.98 | 12.78 | 16.52 | 18.62 | 31.14 | 31.38 | 32.53 | 39.24 | 36.49 | 42.30 |
| Expenses | 13.47 | 13.47 | 12.27 | 15.52 | 16.12 | 29.15 | 28.62 | 29.89 | 36.16 | 33.55 | 38.58 |
| Operating Profit | 0.51 | 0.51 | 0.51 | 1.00 | 2.50 | 1.99 | 2.76 | 2.64 | 3.08 | 2.94 | 3.72 |
| OPM % | 3.65% | 3.65% | 3.99% | 6.05% | 13.43% | 6.39% | 8.80% | 8.12% | 7.85% | 8.06% | 8.79% |
| Other Income | 0.04 | 0.04 | -0.02 | 0.05 | 0.27 | 0.06 | 0.16 | 0.31 | -0.04 | 0.13 | 0.13 |
| Interest | 0.25 | 0.25 | 0.24 | 0.44 | 0.36 | 0.33 | 0.34 | 0.26 | 0.03 | 0.30 | 0.50 |
| Depreciation | 0.13 | 0.13 | 0.15 | 0.84 | 1.07 | 0.92 | 0.89 | 0.88 | 0.94 | 1.00 | 1.02 |
| Profit before tax | 0.17 | 0.17 | 0.10 | -0.23 | 1.34 | 0.80 | 1.69 | 1.81 | 2.07 | 1.77 | 2.33 |
| Tax % | 29.41% | 29.41% | -130.00% | 39.13% | 15.67% | 20.00% | 23.08% | 22.10% | 32.85% | 15.25% | 27.04% |
| Net Profit | 0.12 | 0.12 | 0.24 | -0.33 | 1.14 | 0.65 | 1.29 | 1.41 | 1.39 | 1.50 | 1.50 |
| EPS in Rs | 0.19 | 0.14 | 0.27 | -0.42 | 1.07 | 0.43 | 1.26 | 1.37 | 1.11 | 1.37 | 1.26 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 6.07 | 26.76 | 35.14 | 62.52 | 71.76 | 78.77 |
| Expenses | 5.61 | 25.74 | 31.65 | 57.77 | 66.04 | 72.11 |
| Operating Profit | 0.46 | 1.02 | 3.49 | 4.75 | 5.72 | 6.66 |
| OPM % | 7.58% | 3.81% | 9.93% | 7.60% | 7.97% | 8.45% |
| Other Income | 0.00 | 0.02 | 0.32 | 0.22 | 0.27 | 0.26 |
| Interest | 0.18 | 0.48 | 0.79 | 0.67 | 0.29 | 0.80 |
| Depreciation | 0.12 | 0.28 | 1.91 | 1.81 | 1.82 | 2.02 |
| Profit before tax | 0.16 | 0.28 | 1.11 | 2.49 | 3.88 | 4.10 |
| Tax % | 6.25% | -32.14% | 27.03% | 22.09% | 27.84% | 21.71% |
| Net Profit | 0.15 | 0.36 | 0.81 | 1.94 | 2.79 | 3.00 |
| EPS in Rs | 0.22 | 0.42 | 0.65 | 1.68 | 2.47 | 2.63 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 67% | 31% | 10% | ||
| Compounded Profit Growth | % | 75% | 61% | 6% | ||
| Stock Price CAGR | % | 9% | -15% | -32% | ||
| Return on Equity | % | 11% | 14% | 14% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 3.34 | 4.54 | 4.54 | 4.70 | 9.39 | 9.39 |
| Reserves | 1.44 | 6.45 | 7.17 | 9.49 | 7.17 | 9.51 |
| Borrowings | 7.49 | 7.25 | 10.30 | 8.30 | 7.85 | 16.77 |
| Other Liabilities | 5.73 | 9.85 | 12.29 | 14.67 | 22.98 | 30.40 |
| Total Liabilities | 18.00 | 28.09 | 34.30 | 37.16 | 47.39 | 66.07 |
| Fixed Assets | 1.70 | 2.01 | 10.13 | 10.20 | 10.65 | 12.21 |
| CWIP | 1.22 | 4.48 | 0.02 | 0.02 | 0.03 | 0.05 |
| Investments | 0.00 | 0.49 | 0.02 | 1.88 | 1.88 | 2.88 |
| Other Assets | 15.08 | 21.11 | 24.13 | 25.06 | 34.83 | 50.93 |
| Total Assets | 18.00 | 28.09 | 34.30 | 37.16 | 47.39 | 66.07 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | -0.31 | -1.08 | 1.10 | 5.35 | 4.06 | 1.83 |
| Cash from Investing Activity | -2.02 | -6.14 | -3.44 | -3.61 | -2.30 | -6.57 |
| Cash from Financing Activity | 2.95 | 6.71 | 2.42 | -1.77 | -0.68 | 8.08 |
| Net Cash Flow | 0.62 | -0.51 | 0.07 | -0.03 | 1.08 | 3.34 |
| Free Cash Flow | -2.17 | -4.92 | -4.14 | 3.48 | 1.78 | -1.76 |
| CFO/OP | -67% | -99% | 34% | 116% | 82% | 41% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 430.54 | 124.26 | 129.63 | 78.46 | 107.73 | 108.66 |
| Inventory Days | 369.26 | 103.22 | 128.73 | 67.15 | 67.85 | 93.74 |
| Days Payable | 455.40 | 135.07 | 143.88 | 72.94 | 108.50 | 136.31 |
| Cash Conversion Cycle | 344.41 | 92.41 | 114.48 | 72.67 | 67.07 | 66.09 |
| Working Capital Days | 316.29 | 61.65 | 87.87 | 43.55 | 42.17 | 40.68 |
| ROCE % | 4.85% | 8.78% | 12.75% | 16.08% | 14.84% |
| Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | May 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 71.02% | 71.02% | 70.58% | 70.54% | 71.46% | 71.46% | 71.23% | 68.44% | 68.52% | 68.61% | 68.82% |
| Public | 28.98% | 28.98% | 29.42% | 29.46% | 28.54% | 28.54% | 28.77% | 31.56% | 31.48% | 31.39% | 31.18% |
| No. of Shareholders | 496 | 460 | 291 | 270 | 258 | 233 | 226 | 335 | 333 | 345 | 327 |
Fundamentals
Market Cap₹ 23.4 Cr.
Current Price₹ 25.0
Stock P/E9.49
Book Value₹ 20.1
ROCE14.8 %
ROE13.9 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)10%
Compounded Profit Growth (TTM)6%
Consolidated figures.
Valuation
Market capRs 26 Cr
Enterprise valueRs 33 Cr
P/E (TTM)67.71x
Price to book2.34x
Price to sales0.96x
EV / EBITDA31.27x
EV / EBIT42.79x
EV / sales1.22x
Earnings yield1.48%
Profitability
Operating margin (excl. other income)3.81%
Operating margin (incl. other income)3.89%
EBITDA margin3.89%
Pre-tax margin1.05%
Net profit margin1.42%
ROE4.82%
ROCE4.98%
ROA1.65%
ROIC (approx.)5.65%
Tax rate-32.14%
Other income / net worth0.18%
Growth
Sales growth (latest year)340.86%
Profit growth (latest year)153.33%
Per share
EPS (TTM)Rs 0.40
EPS (latest year)Rs 0.84
Book value per shareRs 11.70
Sales per shareRs 28.50
Cash flow per shareRs -1.15
Free cash flow per shareRs -1.87
Efficiency
Asset turnover0.95x
Fixed asset turnover13.31x
Inventory turnover3.61x
Inventory days101 days
Debtor days124 days
Debtors turnover2.94x
Creditor days136 days
Cash conversion cycle66 days
Working capital days41 days
Leverage
Total debtRs 7 Cr
Cash and bankRs 0 Cr
Net debtRs 7 Cr
Debt to equity0.66x
Net debt / EBITDA6.53x
Interest coverage1.58x
Owners' fund to total sources39.12%
Debt to assets25.81%
Cash flow
Cash from Operating Activity (latest year)Rs -1 Cr
Cash from Investing Activity (latest year)Rs -6 Cr
Cash from Financing Activity (latest year)Rs 7 Cr
Net Cash Flow (latest year)Rs -1 Cr
Free cash flow (latest year)Rs -2 Cr
FCFE (approx.: FCF + change in debt)Rs -2 Cr
Cash from ops / profit, 5 years1.27x
Statement figures
Net sales (TTM)Rs 27 Cr
Net sales (latest year)Rs 27 Cr
Operating profit excl. other income (latest year)Rs 1 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs -0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 21 Cr
Total expenditure (latest year)Rs 26 Cr
Total income (latest year)Rs 27 Cr
Share capitalRs 5 Cr
ReservesRs 6 Cr
Shareholders' fundsRs 11 Cr
Total assetsRs 28 Cr
Net blockRs 2 Cr
Capital work in progressRs 4 Cr
InvestmentsRs 0 Cr
ReceivablesRs 9 Cr
InventoryRs 6 Cr
Other liabilitiesRs 10 Cr
Shares outstanding (crore)0.94
Ownership
Promoter holding68.82% (-2.41 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | WALPAR | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +2.8% | -2.8% | +5.6 pts |
| 1 month | -3.9% | -6.8% | +2.9 pts |
| 3 months | -29.4% | -7.6% | -21.8 pts |
| 6 months | -41.1% | +0.4% | -41.5 pts |
| 1 year | -46.4% | -9.9% | -36.5 pts |
| 2 years | -65.1% | -13.6% | -51.6 pts |
| 3 years | -67.8% | +14.2% | -81.9 pts |
| 5 years | -21.7% | +27.9% | -49.6 pts |
Red flags
F-score 4 of 8| explain | Weak cash conversion Cash from operations was -262% of net profit over the last 2 years |
| look | Share dilution Share count up 36% in a year |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹42 Cr +34.8% vs Mar 2024.
Net profit ₹2 Cr +16.3%.
Against our estimate for Mar 2026: sales -9.1%, profit -21.6% miss.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
High low price variation greater than 100perc in previous 6 monthsLess than 100 unique PAN traded in previous 30 daysMandatory Market making period in SME scrip is overSME scrip is not regularly traded
Quick answers
What is the market cap of Walpar Nutritions Ltd?
Walpar Nutritions Ltd (WALPAR) has a market capitalisation of Rs 23.4 Cr. at the 2026-10-01 close.
What is the P/E ratio of Walpar Nutritions Ltd?
Walpar Nutritions Ltd trades at a P/E of 9.49 on trailing twelve-month profit, at the 2026-10-01 close.
What were Walpar Nutritions Ltd's latest quarterly results?
In the Mar 2026 quarter, Walpar Nutritions Ltd sales was Rs 42 Cr (+34.8% vs Mar 2024) and net profit was Rs 2 Cr.
What is the 52-week high and low of Walpar Nutritions Ltd?
The 52-week high is Rs 50.60 and the 52-week low is Rs 21.25.